ENTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...

Stats
Today's Volume	183 142
Average Volume	264 578
Market Cap	93.04M
EPS	$0 ( 2024-05-10 )
Next earnings date	( $-0.0600 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.29
ATR14	$0.0360 (1.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Yaacov-garbeli Dana	Buy	130 000	Stock Option (right to buy)
2024-04-19	Yaacov-garbeli Dana	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-04-19	Galitzer Hillel	Buy	130 000	Stock Option (right to buy)
2024-04-19	Galitzer Hillel	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-01-12	Taitel Haya	Buy	9 500	Ordinary Shares, par value NIS 0.0000769 per share

INSIDER POWER
100.00
Last 93 transactions
Buy: 4 653 836 \| Sell: 4 161 674

Volume Correlation

Long: 0.02 (neutral)

Short: 0.52 (weak)

Signal:(53.41) Neutral

Entera Bio Ltd Correlation

10 Most Positive Correlations
SWAV	0.947
VITL	0.946
PRIM	0.946
PPC	0.945
TCOM	0.943
INCR	0.941
PNTG	0.94
XBIT	0.937
FNVT	0.936
LGACU	0.935

10 Most Negative Correlations
HCDIP	-0.947
SIRI	-0.939
JACK	-0.934
TTEC	-0.927
XPON	-0.925
PEAR	-0.924
PRTS	-0.923
NLSP	-0.923
FXNC	-0.923
HAIN	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entera Bio Ltd Correlation - Currency/Commodity

-0.75
( moderate negative )

-0.45
( neutral )

0.00
( neutral )

-0.23
( neutral )

0.73
( moderate )

0.07
( neutral )

Entera Bio Ltd Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2022
Revenue:	$134 000
Gross Profit:	$33 000.00 (24.63 %)
EPS:	$-0.450

FY	2021
Revenue:	$571 000
Gross Profit:	$198 000 (34.68 %)
EPS:	$0.425

Financial Reports:

No articles found.

Entera Bio Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.